Michael Kelly

Chief Tech/Sci/R&D Officer at

CureDuchenne

Health Technology

Consumer Services

Finance

Profile

Michael G.
Kelly is currently the Director at Trinds LLC since 2017 and the Chief Scientific Officer at CureDuchenne since 2011.
Previously, he worked as the President, Chief Executive Officer & Director at MyoTherix, Inc. He was also the Research Director at Amgen, Inc. from 1999 to 2000.
Additionally, he worked as a Director at NeoGenesis Pharmaceuticals, Inc. and as the Senior Vice President-Research & Development at Renovis, Inc. Dr. Kelly holds a doctorate degree from The University of Southampton and an undergraduate degree from the University of Ulster.

Michael Kelly active positions

Companies	Position	Start
CureDuchenne CureDuchenne Financial ConglomeratesFinance Provides funding for research projects	Chief Tech/Sci/R&D Officer	13/12/2011
Trinds LLC Trinds LLC Miscellaneous Commercial ServicesCommercial Services Operates as a research organization for neuromuscular diseases	Director/Board Member	01/11/2017

All active positions of Michael Kelly

Former positions of Michael Kelly

Companies	Position	End
AMGEN INC.	Chief Tech/Sci/R&D Officer	01/01/2000
Renovis, Inc. Renovis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products	Chief Tech/Sci/R&D Officer	-
NeoGenesis Pharmaceuticals, Inc. NeoGenesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Used to discover and develop small molecule drugs	Director/Board Member	-
MyoTherix, Inc. MyoTherix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focuses on the development of therapies	Chief Executive Officer	-

See the detail of Michael Kelly's experience

Training of Michael Kelly

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michael Kelly's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	8
Amgen, Inc. Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics	Health Technology
NeoGenesis Pharmaceuticals, Inc. NeoGenesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Used to discover and develop small molecule drugs	Health Technology
Renovis, Inc. Renovis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products	Health Technology
The University of Southampton The University of Southampton Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Ulster University of Ulster Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
CureDuchenne CureDuchenne Financial ConglomeratesFinance Provides funding for research projects	Finance
MyoTherix, Inc. MyoTherix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focuses on the development of therapies	Health Technology
Trinds LLC Trinds LLC Miscellaneous Commercial ServicesCommercial Services Operates as a research organization for neuromuscular diseases	Commercial Services